Delcath Systems DCTH
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$22.7K (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 41.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 6.79% to 5.12% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | Hedge Fund | 2026/Q3 | +3,388,475 | 19.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,289,767 | 11.5% |
| Morgan Stanley | Public Company | 2026/Q3 | +142,574 | 1.6% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +142,574 | 1.6% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +141,723 | 1.0% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +137,595 | 0.4% |
| Acadian Asset Management LLC | Mutual Fund | 2026/Q3 | +114,009 | 0.3% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +104,605 | 0.9% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +89,786 | 2.4% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +80,662 | 2.2% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +64,906 | 0.2% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +66,453 | 0.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +922,336 | 7.8% |
| Algert Global LLC | Hedge Fund | 2026/Q3 | +434,975 | 1.7% |
| ExodusPoint Capital Management, LP | Hedge Fund | 2026/Q3 | +323,916 | 1.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 11 Nov 2026 | Bridget Martell | Director | Derivative Exercise and Sale | -22,500 | $22.26 | – |
| 12 Oct 2026 | Rosalind Advisors, Inc. | Other Disposition | -23,875 | – | 3,276,514 | |
| 12 Oct 2026 | Rosalind Advisors, Inc. | Derivative Exercise and Sale | -3,627 | – | 3,276,514 | |
| 12 May 2026 | Elizabeth Czerepak | Independent Director | Other Derivative Acquisition | +22,500 | $11.61 | 22,500 |
| 12 May 2026 | Steven Salamon | Independent Director | Other Derivative Acquisition | +22,500 | $11.61 | 22,500 |
| 12 May 2026 | John Sylvester | Independent Chairperson | Other Derivative Acquisition | +22,500 | $11.61 | 22,500 |
| 12 May 2026 | Gilad Aharon | Independent Director | Other Derivative Acquisition | +22,500 | $11.61 | 22,500 |
| 12 May 2026 | Bridget Martell | Director | Other Derivative Acquisition | +22,500 | $11.61 | 22,500 |
| 5 Mar 2026 | Sandra Pennell | Chief Financial Officer | Open Market Acquisition | +5,533 | $9.04 | 77,018 |
| 1 Mar 2026 | Gerard Michel | Chief Executive Officer | Open Market Acquisition | +11,200 | $8.96 | 342,034 |
| 16 Feb 2026 | Gerard Michel | Chief Executive Officer | Other Derivative Acquisition | +97,500 | – | 97,500 |
| 16 Feb 2026 | Gerard Michel | Chief Executive Officer | Other Derivative Acquisition | +195,000 | $9.40 | 195,000 |
| 16 Feb 2026 | Vojislav Vukovic | Chief Medical Officer | Other Derivative Acquisition | +28,250 | – | 28,250 |
| 16 Feb 2026 | Vojislav Vukovic | Chief Medical Officer | Other Derivative Acquisition | +56,500 | $9.40 | 56,500 |
| 16 Feb 2026 | Sandra Pennell | Chief Financial Officer | Other Derivative Acquisition | +28,250 | – | 28,250 |
| 16 Feb 2026 | Sandra Pennell | Chief Financial Officer | Other Derivative Acquisition | +56,500 | $9.40 | 56,500 |
| 16 Feb 2026 | Martha Rook | Chief Operating Officer | Other Derivative Acquisition | +28,250 | – | 28,250 |
| 16 Feb 2026 | Martha Rook | Chief Operating Officer | Other Derivative Acquisition | +56,500 | $9.40 | 56,500 |
| 16 Feb 2026 | David Hoffman | General Counsel, Corporate Secretary & Chief Compliance Officer | Other Derivative Acquisition | +28,250 | – | 28,250 |
| 16 Feb 2026 | David Hoffman | General Counsel, Corporate Secretary & Chief Compliance Officer | Other Derivative Acquisition | +56,500 | $9.40 | 56,500 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 1,775,571 | 5.1% | 5.7 |
| 15 Oct 2026 | 1,883,018 | 5.4% | 6.2 |
| 30 Sep 2026 | 1,947,041 | 5.6% | 5.4 |
| 15 Sep 2026 | 2,311,774 | 6.7% | 6.9 |
| 31 Aug 2026 | 2,242,281 | 6.5% | 5.0 |
| 14 Aug 2026 | 2,355,057 | 6.8% | 2.3 |
No comments yet — be the first to weigh in on DCTH.
Sign in to join the discussion.